Tumor Mutational Burden Predicts Survival in Merkel Cell Carcinoma

被引:0
|
作者
Smith, J. D. [1 ]
Bhangale, A. [2 ]
Gu, W. [3 ]
Gensterblum-Miller, E. [3 ]
Brummel, C. [2 ]
Spector, M. E. [4 ]
Mills, R. [3 ]
Brenner, C. [3 ]
机构
[1] Univ Michigan, Dept Otolaryngol, Ann Arbor, MI USA
[2] Univ Michigan, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI USA
[3] Univ Michigan, Ann Arbor, MI USA
[4] Univ Pittsburgh, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
229
引用
收藏
页码:E74 / E74
页数:1
相关论文
共 50 条
  • [41] Systemic Immune Suppression Predicts Diminished Merkel Cell Carcinoma-Specific Survival Independent of Stage
    Paulson, Kelly G.
    Iyer, Jayasri G.
    Blom, Astrid
    Warton, E. Margaret
    Sokil, Monica
    Yelistratova, Lola
    Schuman, Louise
    Nagase, Kotaro
    Bhatia, Shailender
    Asgari, Maryam M.
    Nghiem, Paul
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (03) : 642 - 646
  • [42] Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival
    Vandeven, Natalie
    Lewis, Christopher W.
    Makarov, Vladimir
    Riaz, Nadeem
    Paulson, Kelly G.
    Hippe, Daniel
    Bestick, Amy
    Doumani, Ryan
    Marx, Tessa
    Takagishi, Seesha
    Chan, Timothy A.
    Choi, Jaehyuk
    Nghiem, Paul
    CLINICAL CANCER RESEARCH, 2018, 24 (04) : 963 - 971
  • [43] Actionable mutations and mutational burden in renal cell carcinoma
    Mockus, Susan M.
    Patterson, Sara E.
    Pettus, Jason R.
    Tsongalis, Gregory J.
    CANCER RESEARCH, 2016, 76
  • [44] Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1
    Alghamri, Mahmoud S.
    Thalla, Rohit
    Avvari, Ruthvik P.
    Dabaja, Ali
    Taher, Ayman
    Zhao, Lili
    Ulintz, Peter J.
    Castro, Maria G.
    Lowenstein, Pedro R.
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [45] Merkel Cell Polyomavirus Antibody in Tumor and Plasma Specimens in Patients with Merkel Cell Carcinoma
    Schmocker, Ryan K.
    Nodit, Laurentia
    Ward, Andrew J.
    Lewis, James M.
    McLoughlin, James M.
    Enomoto, Laura M.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (01) : 464 - 473
  • [46] Spotlight on tumor mutational burden in patients with non-small cell lung carcinoma Preface
    Ilie, Marius
    Hofman, Paul
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 614 - 615
  • [47] Relationship of tumor mutational burden (TMB) to immunotherapy response in metastatic renal cell carcinoma (mRCC).
    Maia, Manuel C.
    Almeida, Lorena
    Bergerot, Paulo Gustavo
    Dizman, Nazli
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [48] The burden of Merkel cell carcinoma attributable to immunosuppression, ultraviolet radiation, and Merkel cell polyomavirus in the United States
    Tribble, Jacob T.
    Volesky-Avellaneda, Karena
    Luo, Qianlai
    Sargen, Michael R.
    Brownell, Isaac
    Cahoon, Elizabeth K.
    Shiels, Meredith
    Pfeiffer, Ruth
    Moreno, Adrianne
    Hernandez, Brenda Y.
    Engels, Eric
    CANCER RESEARCH, 2024, 84 (06)
  • [49] Metastatic basal cell carcinoma with a high tumor mutational burden that achieved complete response with pembrolizumab
    Yamakawa, Kohei
    Ogata, Dai
    Hiki, Kojiro
    Jinnai, Shunichi
    Namikawa, Kenjiro
    Takahashi, Akira
    Yamazaki, Naoya
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (02) : E79 - E80
  • [50] Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With Elevated Tumor Mutational Burden
    Necchi, Andrea
    Spiess, Philippe E.
    de Padua, Tiago Costa
    Li, Roger
    Grivas, Petros
    Huang, Richard S. P.
    Lin, Douglas I.
    Danziger, Natalie
    Ross, Jeffrey S.
    Jacob, Joseph M.
    Sager, Rebecca A.
    Basnet, Alina
    Li, Gerald
    Graf, Ryon P.
    Pavlick, Dean C.
    Bratslavsky, Gennady
    JAMA NETWORK OPEN, 2023, 6 (12) : E2348002